124 related articles for article (PubMed ID: 17917571)
1. Premalignant cervical lesions are characterized by dihydrofolate reductase gene amplification and c-Myc overexpression: possible biomarkers.
Guijon FB; Greulich-Bode K; Paraskevas M; Baker P; Mai S
J Low Genit Tract Dis; 2007 Oct; 11(4):265-72. PubMed ID: 17917571
[TBL] [Abstract][Full Text] [Related]
2. c-Myc-associated genomic instability of the dihydrofolate reductase locus in vivo.
Taylor C; Mai S
Cancer Detect Prev; 1998; 22(4):350-6. PubMed ID: 9674878
[TBL] [Abstract][Full Text] [Related]
3. c-Myc dependent initiation of genomic instability during neoplastic transformation.
Taylor C; Jalava A; Mai S
Curr Top Microbiol Immunol; 1997; 224():201-7. PubMed ID: 9308243
[TBL] [Abstract][Full Text] [Related]
4. Amplification and overexpression of TP63 and MYC as biomarkers for transition of cervical intraepithelial neoplasia to cervical cancer.
Zhu D; Jiang XH; Jiang YH; Ding WC; Zhang CL; Shen H; Wang XL; Ma D; Hu Z; Wang H
Int J Gynecol Cancer; 2014 May; 24(4):643-8. PubMed ID: 24662128
[TBL] [Abstract][Full Text] [Related]
5. FHIT and C-MYC expression in cervical histology and cytology as biomarkers for detecting high-grade intraepithelial neoplasia in human papillomavirus-positive women.
Yang F; Cui Z; Liao Y; Tian R; Fan W; Jin Z; Hu Z; Yao S
Cancer Biomark; 2020; 27(3):303-312. PubMed ID: 31771040
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
7. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
8. c-Myc overexpression associated DHFR gene amplification in hamster, rat, mouse and human cell lines.
Mai S; Hanley-Hyde J; Fluri M
Oncogene; 1996 Jan; 12(2):277-88. PubMed ID: 8570205
[TBL] [Abstract][Full Text] [Related]
9. c-myc gene amplification detected in preinvasive intraepithelial cervical lesions.
Golijow CD; Abba MC; Mourón SA; Gómez MA; Dulout FN
Int J Gynecol Cancer; 2001; 11(6):462-5. PubMed ID: 11906549
[TBL] [Abstract][Full Text] [Related]
10. c-myc Gene Copy Number Variation in Cervical Exfoliated Cells Detected on Fluorescence in situ Hybridization for Cervical Cancer Screening.
Zhao WH; Hao M; Cheng XT; Yang X; Wang ZL; Cheng KY; Liu FL; Bai YX
Gynecol Obstet Invest; 2016; 81(5):416-23. PubMed ID: 26808725
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia.
Dellas A; Schultheiss E; Holzgreve W; Oberholzer M; Torhorst J; Gudat F
Int J Gynecol Pathol; 1997 Jul; 16(3):212-8. PubMed ID: 9421085
[TBL] [Abstract][Full Text] [Related]
13. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analyses of hTERC (3q26) and MYC (8q24) genes amplifications in correlation with oncogenic human papillomavirus infection in Czech patients with cervical intraepithelial neoplasia and cervical carcinomas.
Kuglik P; Kasikova K; Smetana J; Vallova V; Lastuvkova A; Moukova L; Cvanova M; Brozova L
Neoplasma; 2015; 62(1):130-9. PubMed ID: 25563377
[TBL] [Abstract][Full Text] [Related]
15. [Comparison and analysis of expression of c-myc and p16 in cervical carcinoma].
Ruan YH; Wei WL; Zhang HX; Liang ZN; Liu BY; Chen Y
Ai Zheng; 2003 Jun; 22(6):602-6. PubMed ID: 12948409
[TBL] [Abstract][Full Text] [Related]
16. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
17. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of c-myc precedes amplification of the gene encoding dihydrofolate reductase.
Mai S
Gene; 1994 Oct; 148(2):253-60. PubMed ID: 7958952
[TBL] [Abstract][Full Text] [Related]
19. [Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen].
Li YB; Wulan N; Liu ZH; Li J; Wang C; Zhou YQ; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):946-50. PubMed ID: 20193234
[TBL] [Abstract][Full Text] [Related]
20. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
